Northland Capmk Issues Negative Forecast for DocGo Earnings

DocGo Inc. (NASDAQ:DCGO) – Investment analysts at Northland Capmk lowered their Q2 2025 earnings per share estimates for shares of DocGo in a research report issued to clients and investors on Sunday, May 11th. Northland Capmk analyst M. Latimore now expects that the company will post earnings of ($0.07) per share for the quarter, down from their prior forecast of $0.03. The consensus estimate for DocGo’s current full-year earnings is $0.25 per share. Northland Capmk also issued estimates for DocGo’s Q3 2025 earnings at ($0.06) EPS, Q4 2025 earnings at ($0.05) EPS and FY2025 earnings at ($0.26) EPS.

DocGo (NASDAQ:DCGO) last issued its earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.08). The company had revenue of $96.03 million during the quarter, compared to analyst estimates of $104.25 million. DocGo had a return on equity of 8.90% and a net margin of 4.35%.

Other equities analysts have also recently issued reports about the company. Canaccord Genuity Group reaffirmed a “hold” rating and issued a $1.45 target price (down previously from $5.00) on shares of DocGo in a research report on Monday. Needham & Company LLC decreased their target price on DocGo from $4.00 to $3.00 and set a “buy” rating for the company in a research report on Friday, May 9th. Deutsche Bank Aktiengesellschaft cut DocGo from a “buy” rating to a “hold” rating and decreased their target price for the stock from $5.00 to $2.85 in a research report on Friday, February 28th. BTIG Research cut DocGo from a “buy” rating to a “neutral” rating in a research report on Friday, May 9th. Finally, Stifel Nicolaus decreased their target price on DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a research report on Friday, February 28th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $3.56.

DocGo Price Performance

Shares of NASDAQ DCGO opened at $1.40 on Wednesday. The stock has a market capitalization of $142.78 million, a price-to-earnings ratio of 5.00, a PEG ratio of 14.16 and a beta of 1.14. The stock’s fifty day simple moving average is $2.39 and its 200 day simple moving average is $3.63. DocGo has a 52-week low of $1.35 and a 52-week high of $5.68.

Institutional Trading of DocGo

A number of institutional investors have recently bought and sold shares of DCGO. Jefferies Financial Group Inc. boosted its position in DocGo by 6,874.1% during the first quarter. Jefferies Financial Group Inc. now owns 2,029,456 shares of the company’s stock valued at $5,358,000 after purchasing an additional 2,000,356 shares during the last quarter. WCM Investment Management LLC boosted its position in DocGo by 64.2% during the fourth quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company’s stock valued at $18,637,000 after purchasing an additional 1,687,100 shares during the last quarter. American Century Companies Inc. boosted its position in DocGo by 175.5% during the first quarter. American Century Companies Inc. now owns 1,245,894 shares of the company’s stock valued at $3,289,000 after purchasing an additional 793,640 shares during the last quarter. P.A.W. Capital Corp boosted its position in DocGo by 25.0% during the first quarter. P.A.W. Capital Corp now owns 2,000,000 shares of the company’s stock valued at $5,280,000 after purchasing an additional 400,000 shares during the last quarter. Finally, Northern Trust Corp boosted its position in DocGo by 24.9% during the fourth quarter. Northern Trust Corp now owns 1,606,139 shares of the company’s stock valued at $6,810,000 after purchasing an additional 320,133 shares during the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.